With the help of Big Beer and Big Pharma, Brendan Kennedy’s Canadian cannabis company Tilray has unexpectedly become America’s gateway to the legal marijuana industry. It’s just after 6, on a pitch-dark morning in December, and Brendan Kennedy is standing over the stove, wearing shorts and a vest, meditatively melting butter in a pancake pan. […]
Brendan Kennedy
Tilray® Expands Leadership Team in Europe to Drive Global Expansion Strate
PRESS RELEASE Former pharmaceutical leader from Grünenthal joins Tilray, strengthening the company’s position in Europe NANAIMO, B.C – Today, Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announces the expansion of its global senior leadership team with the appointment of Sascha Mielcarek as Managing Director, Europe. Sascha Mielcarek comes to […]
Tilray® to Acquire Natura Naturals Holdings Inc. for up to C$70 Million Subject to Performance Milestone
PRESS RELEASE Acquisition increases the Company’s capacity to supply branded cannabis products NANAIMO, B.C. – Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced it has entered into a definitive agreement (“the Agreement”) pursuant to which Tilray, through a wholly-owned subsidiary, will acquire all of […]
Tilray® and Authentic Brands Group Sign Global Revenue Sharing Agreement to Develop and Market Consumer Cannabis Brands
PRESS RELEASE Agreement leverages Tilray’s cannabis expertise and ABG’s extensive portfolio of iconic brands that span the entertainment, fashion, streetwear, active, home and health and wellness sectors NANAIMO, B.C. – Today, Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production and distribution, and Authentic Brands Group (ABG), an owner of a portfolio of global lifestyle and […]
Canadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal
Tilray has signed a global partnership with a division of Swiss drug giant Novartis to develop and distribute its medical marijuana in legal jurisdictions around the world. The Canadian pot firm said Tuesday it’s reached an agreement with Sandoz to boost the availability of medical cannabis products globally, building on an existing alliance with Sandoz […]
Tilray® Strengthens Presence in Latin America with Acquisition of Alef Biotechnology
PRESS RELEASE NANAIMO, British Columbia and SANTIAGO, Chile – Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research and production, today announced that it has completed an acquisition of its existing import and distribution partner Alef Biotechnology SpA (“Alef”). The acquisition will allow Tilray to import, produce and distribute Tilray branded medical cannabis products […]
Tilray, Inc. Reports Second Quarter 2018 Earnings
PRESS RELEASE NANAIMO, BRITISH COLUMBIA – Tilray, Inc., (“Tilray” or the “Company”) (NASDAQ: TLRY) a global pioneer in cannabis production and distribution, today reported financial results for second quarter and six months ended June 30, 2018. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “We are very pleased with […]
OOOO…(what a week it was) CANADA, “our home and native land. True patriot love in all of us command”
What started out as just another one of those long conference weeks morphed into the “Brave New World of Cannabis” with the Tuesday morning announcement of Constellation Brands $5 Billion Canadian dollar (yes with a B not an M) investment in Canopy Growth. Some would argue it was the most significant financial news ever for […]
SEC vs. Tilray: What regulators wanted to know about the largest U.S. pot IPO
Tilray removed entire CEO letter from IPO filing, according to SEC documents As the largest pot IPO in the U.S. was on deck earlier this year, the Securities and Exchange Commission sought to cut down on Tilray Inc.’s soaring rhetoric and add disclosures about the side effects of weed, according to SEC documents made public […]
Tilray Inc. Announces Filing of a U.S. Registration Statement and Application for Proposed IPO on Nasdaq
PRESS RELEASE Company has also filed a Canadian Preliminary Prospectus for Proposed IPO, in order to qualify the offering of securities in Canada and to ensure purchasers in Canada are not subject to resale restrictions NANAIMO, BRITISH COLUMBIA – Tilray Inc., a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, today announced the filing of a registration statement with […]
Tilray Appoints Majority Women Led Board of Directors
PRESS RELEASE New Board members bring expertise in global partnerships, distribution, licensing, public policy, and international business diplomacy On behalf of the entire Tilray team, I am pleased to share that today Tilray announced the appointment of Rebekah Dopp, a Principal in Global Partnerships at Google, Maryscott “Scotty” Greenwood, CEO of the Canadian American Business Council […]
Tilray Launches High Park Company to Produce and Distribute Adult-Use Cannabis in Canada
PRESS RELEASE In anticipation of the historic legalization of adult-use cannabis in Canada, I am pleased to share that today Tilray, Inc. (“Tilray”) announced the creation of wholly-owned subsidiary High Park Company™ (“High Park”) to produce and distribute a broad-based portfolio of cannabis brands and products. As a part of this announcement, we also shared that we are […]
Tilray Forms Strategic Alliance with Leading Pharmaceutical Company
PRESS RELEASE On behalf of the entire Tilray team, I am pleased to announce that Tilray has formed a strategic alliance with a major pharmaceutical company. Tilray is now allied with Sandoz Canada Inc., a part of the Novartis group and a global leader in generic pharmaceuticals. This alliance is a major milestone on the long road […]
Tilray® Announces Completion of Series A Funding Round Led by Global Institutional Investors
PRESS RELEASE C$60 million Series A financing will enable Tilray to increase production capacity and expand distribution in North America and Europe TORONTO – Tilray, a global pioneer in medical cannabis research, cultivation, processing and distribution, today announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a […]
Privateer Holdings Closes $100+ Million Funding Round, Announces $5 Million Equity Pledge
PRESS RELEASE Firm’s founders pledge $5 million worth of their personal equity stakes in the firm, which will grow over time, to help repair generations of harm in the United States, Canada, and globally SEATTLE – Privateer Holdings, the world’s leading private equity firm investing exclusively in legal cannabis, today announced the completion of its […]
Tilray Receives License to Produce Medical Cannabis in the European Union
PRESS RELEASE Company Announces €20 Million Investment to Build EU Campus and Begin Operations this Year Located in the BIOCANT Research Park in Cantanhede, Portugal, Tilray’s EU Campus will cultivate, process, package, and distribute GMP-grade medical cannabis products to qualified patients, pharmacies, and researchers throughout the European common market. Phased build-out of the EU Campus […]
